Correction: Report of Specific Cardiovascular Outcomes of the ADVANTAGE Trial

We recently published a letter by Egilman and Presler (1) that cited a letter from an official at Merck & Co., Inc. (Whitehouse Station, New Jersey) to the U.S. Food and Drug Administration (FDA) …

[Full Text of this Article]
« Previous | Next Article »Table of Contents

This Article

  1. Ann Intern Med June 20, 2006 vol. 144 no. 12 943
  1. » Excerpt
  2. Full Text
  3. Full Text (PDF)

Rapid Responses

  1. Submit a response
  2. No responses published

Current Issue

  1. December 1, 2009, 151 (11)
  1. Alert me to current issues